N/A
Completed N=162
Invasive Candidiasis in Saudi ICUs
Source: ClinicalTrials.gov NCT01490684 ↗Enrolled (actual)
162
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcomePrimary: Hospital Mortality — 95 Participants
Summary
Epidemiology and clinical outcomes of invasive candidiasis in critically ill patients in Saudi Arabia is not well studied. This observational study objectives include to determine the epidemiology, risk factors and outcomes of invasive Candida infection in critically ill patients in Saudi Arabia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Hospital Mortality |
95 | — |
| SECONDARY ICU Mortality |
83 | — |
| SECONDARY Duration of Mechanical Ventilation |
— | — |
| SECONDARY Length of Stay in the ICU |
42.4 | — |
| SECONDARY Length of Stay in the Hospital |
88.8 | — |
Eligibility Criteria
Inclusion Criteria
- adult patients (> 18 years)
- develop invasive candidiasis as per prespecified definitions during ICU stay
- In addition, patients who had invasive candidiasis within 72 hours of ICU admission will be included
Exclusion Criteria
- Diagnosis of invasive candidiasis (definite or probable) more than 72 hours before ICU admission.
- Diagnosis of invasive candidiasis (definite or probable) within 72 hours of ICU admission, but the admission to ICU for an unrelated reason.
- Readmission to the ICU during the same hospitalization with invasive candidiasis occurring during one of the previous admissions.
Data sourced from ClinicalTrials.gov (NCT01490684). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.